• Meta-analysis
  • Treatment: Trigger Point Injection
Clinical RelevanceDOI 4 min read
Jump to:

Patient-friendly summary

Best fit for

Adults with chronic head, neck, or shoulder painPatients who haven't found relief with other treatments

If you read nothing else

This review finds local anesthetic injections can reduce head and neck myofascial pain in the short term compared to dry needling and placebo.

Bottom line

Local anesthetic injections seem to provide short-term pain relief for head and neck myofascial pain, worth discussing with your provider.

Preliminary evidence

Published

2019
7 years ago
Recent

Evidence hierarchy

Meta-analysis ◀ this study
Systematic Review
RCT
Cohort
Case-Control
Case Report
Expert Opinion

Study participants

n=88418 to 75Female predominance noted

Adult patients with myofascial pain syndrome in the head, neck, and shoulder regions

Full research — for clinicians and curious readers

Study Summary

Background

Myofascial pain syndrome (MPS) affects 13.8% of the US population, with the head, neck, and shoulders being the most common sites. This condition is characterized by deep aching pain arising from trigger points—tender spots in muscle bands that reproduce the patient's pain when pressed. While trigger point injections are considered one of the most effective treatments, it remains unclear whether using local anesthetics provides additional benefits over dry needling (needling without medication). This systematic review aimed to determine whether local anesthetic injections are more effective than dry needling, placebo treatments, or other interventions for head and neck myofascial pain.

What They Did

The researchers conducted a comprehensive search of four major medical databases through April 2018, finding 324 initial references. After screening, they included 15 randomized controlled trials involving 884 adult patients diagnosed with myofascial pain syndrome. The studies compared local anesthetics (primarily lidocaine 0.5-2% or procaine 1%) to dry needling, saline placebo injections, or other treatments. The primary outcome was pain intensity measured on a 0-10 visual analog scale.

They also examined secondary outcomes including pressure pain thresholds, range of motion, and depression scores. The researchers performed separate meta-analyses for different comparison groups and conducted sensitivity analyses to test the reliability of their findings.

What They Found

When all studies were included, local anesthetic injections showed a statistically significant pain reduction of 1.585 points compared to dry needling at 1-4 weeks (p = 0.020). However, this advantage disappeared when only high-quality, double-blinded studies were analyzed, with no significant difference found (p = 0.331). Compared to placebo injections, local anesthetics showed a smaller but significant improvement of 0.767 points (p = 0.007). Subgroup analyses revealed that studies with higher bias risk were more likely to show benefits for local anesthetics, and studies that included home exercises showed better results than those without.

No significant differences were found in pressure pain thresholds, range of motion, or depression scores. Adverse effects were generally mild, including soreness, burning sensation, and occasional dizziness.

What This Means

This review provides only low-quality evidence supporting local anesthetic injections over dry needling for head and neck trigger points. The difference may not be clinically meaningful, and the apparent benefit might be due to study bias or accompanying home treatments rather than the medication itself. For patients, this suggests that dry needling alone may be just as effective as injections with local anesthetics, potentially avoiding the small risks and costs associated with medications. For clinicians, these findings support current practice guidelines that recommend starting with less invasive treatments.

The results highlight the need for larger, well-designed studies with better blinding and standardized protocols to definitively determine whether local anesthetics provide meaningful benefits over dry needling for myofascial trigger points.

75/100
Evidence StrengthStrong
Study Quality
Sample Size
Replication
VAS Pain Reduction (vs dry needling)
1.585
Double-blind Studies (non-significant)
p=0.331
Total Patients Analyzed
884
Studies Included
15

Results Comparison

VAS Pain Reduction (0-10 scale)

points
Local Anesthetic1.585 points
Dry Needling0 points

Key Findings

FindingDetailImpact
Local anesthetic showed modest pain reduction compared to dry needling1.585 points improvement on 0-10 VAS scale, but effect disappeared in double-blind studiesMedium
Benefits may be due to study bias rather than medication effectHigh-risk studies showed significant benefits while low-risk studies did not (p=0.331)High
No differences in secondary outcomesNo significant improvements in pressure pain threshold, range of motion, or depressionMedium
Home exercise programs may contribute to outcomesStudies with home treatments showed better results than those withoutMedium
Adverse effects were minimalMainly soreness and burning sensation at injection site, occasional dizzinessLow
Evidence quality was consistently lowAll meta-analyses rated as low quality due to bias risk and small sample sizesHigh
Study Methodology
Study Design
Systematic review with meta-analysis
Sample Size
884
Duration
1-8 weeks follow-up
Population
Adults with head, neck, and shoulder myofascial pain syndrome
Outcome Measures
Visual analog scale (VAS) · Pressure pain threshold · Range of motion · Depression scales

Strengths

  • Comprehensive systematic search of multiple databases
  • Large combined sample size of 884 patients
  • Separate analyses for different comparison groups
  • Sensitivity analyses including only double-blind studies
  • Used validated outcome measures like VAS pain scales
  • Assessed risk of bias using Cochrane methods

Limitations

  • High or unclear risk of bias in all included studies
  • Significant clinical heterogeneity across studies
  • Small individual study sample sizes
  • Short follow-up periods (maximum 8 weeks)
  • Inconsistent co-interventions and home treatments
  • Limited long-term efficacy data

Key Takeaways for Patients

What This Means for You

  1. Trigger point injections with numbing medication may provide only small additional benefits over dry needling alone

  2. The needle insertion itself appears to be the main therapeutic factor, not the medication

  3. Home exercises and self-care may be just as important as the injection technique used

  4. Both injection methods appear safe with minimal side effects like temporary soreness

  5. More research is needed to determine if local anesthetics provide meaningful clinical benefits

Read the Full Paper

Access the complete peer-reviewed study from Journal of Oral & Facial Pain and Headache

View Full Study

Related Research

●●●●● LandmarkMeta-analysis

Trigger Point Injections Versus Medical Management for Acute Myofascial Pain: A Systematic Review and Meta-Analysis

Haroutiun Hamzoian & Vahe Zograbyan·Cureus·2023

A meta-analysis of four RCTs found that trigger point injections significantly reduced acute myofascial pain compared with medical management alone (SMD -2.09; 95% CI -3.34 to -0.85; P = 0.001), though the authors flag notable heterogeneity and bias concerns.

Trigger Point InjectionRead →
●●●●● LandmarkNarrative Review

Treatment of Myofascial Pain Syndrome

Hong, Chang-Zern·Current Pain and Headache Reports·2006

Comprehensive review establishing that successful myofascial pain treatment requires addressing underlying causes before trigger point therapy. Multiple treatment modalities are effective, but lasting relief depends on treating root pathology and patient education.

Trigger Point InjectionRead →
●●●●○ StrongCase Report/Series

The paravertebral fascial plane block: A novel, ultrasound-guided technique for paraspinal neck and back pain

Aulia et al.·American Journal of Emergency Medicine·2026

A novel ultrasound-guided fascial injection technique provided rapid, sustained pain relief for 11 emergency department patients with refractory paraspinal myofascial pain. Pain scores dropped from 9/10 to 1/10 at 48-hour follow-up with no complications.

Trigger Point InjectionRead →
●●●●○ StrongNarrative Review

Integrating Ultrasound-Guided Injections and Peripheral Magnetic Stimulation in Chronic Myofascial/Lumbar Pain

Wu et al.·Life·2025

This perspective article proposes combining ultrasound-guided multifidus injections with repetitive peripheral magnetic stimulation as a multimodal approach for chronic myofascial and lumbar pain. Preliminary findings from a pilot study of three patients suggest significant pain and disability reduction after 12 combined treatment sessions.

Trigger Point InjectionRead →